Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants

Lebel, Marie-Ève; Chartrand, Karine; Leclerc, Denis et Lamarre, Alain (2015). Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants Vaccines (Basel) , vol. 3 , nº 3. pp. 620-37. DOI: 10.3390/vaccines3030620.

Prévisualisation

PDF - Version publiée Disponible sous licence Creative Commons Public Domain Dedication. Télécharger (227kB) | Prévisualisation

Résumé

Vaccines are considered one of the greatest medical achievements in the battle against infectious diseases. However, the intractability of various diseases such as hepatitis C, HIV/AIDS, malaria, tuberculosis, and cancer poses persistent hurdles given that traditional vaccine-development methods have proven to be ineffective; as such, these challenges have driven the emergence of novel vaccine design approaches. In this regard, much effort has been put into the development of new safe adjuvants and vaccine platforms. Of particular interest, the utilization of plant virus-like nanoparticles and recombinant plant viruses has gained increasing significance as an effective tool in the development of novel vaccines against infectious diseases and cancer. The present review summarizes recent advances in the use of plant viruses as nanoparticle-based vaccines and adjuvants and their mechanism of action. Harnessing plant-virus immunogenic properties will enable the design of novel, safe, and efficacious prophylactic and therapeutic vaccines against disease.

Type de document:	Article
Mots-clés libres:	adjuvant; immune response; production methods; recombinant plant virus; vaccine
Centre:	Centre INRS-Institut Armand Frappier
Date de dépôt:	10 mars 2016 19:29
Dernière modification:	10 mars 2016 19:29
URI:	https://espace.inrs.ca/id/eprint/3221

Gestion Actions (Identification requise)

Modifier la notice